Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer

Clinical Cancer Research

Volumn 6, Issue 7, 2000, Pages 2803-2807

  Cascinu, Stefano ^a,e   Staccioli, Maria Pia ^b   Gasparini, Giampietro ^c   Giordani, Paolo ^b   Catalano, Vincenzo ^b   Ghiselli, Roberto ^d   Rossi, Cristina ^b   Baldelli, Anna Maria ^b   Graziano, Francesco ^b   Saba, Vittorio ^d   Muretto, Pietro ^b   Catalano, Giuseppina ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b Azienda Ospedaliera Osp S S   (Italy)

^c BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^e UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; ENDOTHELIAL GROWTH FACTORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033941120     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Tangen, C. M., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., Veeder, M. H., and Mailliard, J. A. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann. Intern. Med., 122: 321-326, 1995.
2. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet, 345: 939-944, 1995.
3. Mamounas, E., Wieand, S., Wolmark, N., Bear, H. D., Atkins, J. N., Song, K., Jones, J., and Rockette, H. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, C-04). J. Clin. Oncol., 17: 1349-1355, 1999.
4. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. J. Clin. Oncol., 17: 1356-1363, 1999.
5. 0 colorectal carcinoma. Cancer (Phila.), 83: 1081-1085, 1998.
6. Liefers, G. J., Cleton Jansen, A. M., vand de Velde, C. J. H., Hermans, J., van Krieken, J. H. J. M., Cornelisse, C. J., and Tollenaar, R. A. E. M. Micrometastases and survival in stage II colorectal cancer. N. Engl. J. Med., 339: 223-228, 1998.
7. Tokunaga, T., Oshika, Y., Abe, Y., Ozeki, Y., Sadahiro, S., Kijiima, H., Tsuchida, T., Yamazaki, H., Ueyama, Y., Tamaoki, N., and Nakamura, M. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor performance prognosis in colon cancer. Br. J. Cancer, 77: 998-1002, 1998.
8. Takahashi, Y., Mai, M., Kitadai, Y., Bucana, C., Cleary, K. R., and Ellis, L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res., 55: 3964-3968, 1995.
9. Ishigami, S. I., Arii, S., Furutani, M., Niwano, M., Harada, T., Mizumoto, M., Mori, A., Onodera, H., and Imamura, M. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br. J. Cancer, 78: 1379-1384, 1998.
10. Nakata, S., Ito, K., Fujimori, M., Shingu, K., Kajikawa, S., Adachi, W., Matsuyama, I., Tsuchiya, S., Kuwano, M., and Amano, J. Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers. Int. J. Cancer, 79: 179-186, 1998.
11. Lindmark, G., Gerdin, B., Sundberg, C., Pahlman, L., Bergstrom, R., and Glimelius, B. Prognostic significance of the microvascular count in colorectal cancer. J. Clin. Oncol., 14: 461-466, 1996.
12. Takebayashi, Y., Akiyama, S., Yamada, K., Akiba, S., and Aikou, T. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer (Phila.), 78: 226-231, 1996.
13. Banner, B. F., Whitehouse, R., Baker, S., and Swanson, R. Tumor angiogenesis in stage II colorectal carcinoma. Am. J. Clin. Pathol., 109: 733-737, 1998.
14. Takahashi, Y., Tucker, S. L., Kitadai, Y., Koura, A. N., Bucana, C. D., Cleary, K. R., and Ellis, L. M. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch. Surg., 132: 541-546, 1997.
15. Saito, H., Tsujitani, S., Ikeguchi, M., and Kaibara, N. Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. Br. J. Cancer, 78: 1573-1577, 1998.
16. Glantz, S. A. Primer of Biostatistics, 3rd ed. New York: McGraw-Hill Book Co., 1992.
17. Harrington, D. P. The tea leaves of small trials. J. Clin. Oncol., 17: 1336-1338, 1999.
18. Tominaga, T., Sakabe, T., Koyama, Y., Hamano, K., Yasutomi, M., Takahashi, T., Kodaira, S., Kato, T., and Ogawa, N. Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Cancer (Phila.), 78: 403-408, 1996.
19. Jen, J., Kim, H., Piantadosi, S., Liu, Z. F., Levitt, R. C., Sistonen, P., Kinzler, K. W., Vogelstein, B., and Hamilton, S. R. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N. Engl. J. Med., 335: 1727-1732, 1994.
20. Ahnen, D. J., Feigl, P., Quan, G., Fenoglio-Preiser, C., Lovato, L. C., Bunn, P. A., Jr., Stemmerman, G., Wells, J. D., Macdonald, J. S., and Meyskens, F. L. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group Study. Cancer Res., 58: 1149-1158, 1998.
21. Frank, R. E., Saclarides, T. J., Leurgans, S., Speziale, N. J., Drab, E. A., and Rubin, D. B. Tumor angiogenesis as predictor of recurrence and survival in patients with node negative colon cancer. Ann. Surg., 222: 695-699, 1995.
22. Ferrara, N., and Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr. Rev., 18: 4-25, 1997.
23. Martiny-Baron, G., and Marmè, D. VEGF-mediated tumor angiogenesis: a new target for cancer therapy. Curr. Opin. Biotechnol., 18: 675-680, 1995.